SUPN
SUPERNUS PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$39.84
+5.17%Forward multiples
Based on analyst estimates
- P/E forward
- 12.33x
- P/E 2026E
- 15.55x
- P/E 2027E
- 9.16x
- P/E 2028E
- 7.30x
- P/S forward
- 2.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.25x
- Price / sales
- 2.79x
- Price / cash flow
- 116.50x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 2.39x
- EV / EBITDA
- -125.27x
- EV / EBIT
- -17.78x
- Market cap
- $2.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026